Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Apotex, assumption, CAD, conventional, coordinating, divest, forum, freestanding, Gador, HKF, Hong, instrument, Kong, Laboratorio, Lastly, methodology, proceed, PSO, revoke, shareholder, shortfall, simulation, tied, Unified, Unitary, UPC, USD
Removed:
AbriladaTM, accelerate, Alvotech, AmjevitaTM, announcement, appraisal, Biocon, Boehringer, bona, Cuban, CyltezoTM, deferred, exemption, fide, forfeited, guaranty, HadlimaTM, historically, Hulio, HyrimozTM, inducement, Ingelheim, invasion, iv, largest, LIBOR, mail, mammalian, Mark, mg, mix, nationwide, PBC, PFS, preference, properly, resolving, restraining, Rituxan, rituximab, Samsung, specialty, stipulation, tangible, therewith, topline, Tranche, uncommitted, unexercised
Filing tables
Filing exhibits
Related press release
Associated CHRS transcripts
CHRS similar filings
Filing view
External links